جست‌وجوی استاد و پژوهشگر

Bradley McConnellمشاهده پروفایل

استاد

• Cardiac Signaling
• Cardiac Repair
• β-Adrenergic Receptor Physiology
• +۴ مورد دیگر

Bradley McConnell is a Professor of Pharmacology and Assistant Chair in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy. He holds joint faculty appointments in the Department of Biology and Biochemistry (College of Natural Sciences and Mathematics) and is affiliated with multiple institutes including the Drug Discovery Institute (UH), Cardiovascular Research Institute (Baylor College of Medicine), and the Gulf Coast Consortia (Texas Medical Center). Education: B.S. in Biology (Pennsylvania State University), Ph.D. in Physiology and Biophysics (Case Western Reserve University), and Postdoctoral Fellow in Genetics (Harvard Medical School/Howard Hughes Medical Institute). Research focuses on cardiac signaling mechanisms in normal and diseased hearts, including β-adrenergic receptor signaling, AKAP-mediated pathways, and cell-based therapies for cardiac repair. Key projects involve reprogramming progenitor cells into functional cardiac cells, biased signaling studies, and understanding AKAP 'signalosomes' in cAMP pathways. His awards include the American Physiological Society Fellow (2014), American Heart Association Fellow (2011), and multiple teaching/mentoring awards from UH. He chairs the ASPET Cardiovascular Pharmacology Programming Committee and participates in national peer review committees. McConnell collaborates across disciplines through memberships in the Cougar Chairs Leadership Academy and National Center for Faculty Development. His lab integrates translational approaches—combining molecular biology, mouse models, and clinical insights—to advance heart repair therapies.

• Chromatin Regulation
• Stem Cell Biology
• Epigenetics
• +۳ مورد دیگر

Thomas Fazzio is a Professor at the University of Massachusetts Chan Medical School, affiliated with the T.H. Chan School of Medicine and multiple departments including Molecular, Cell and Cancer Biology, Biochemistry and Molecular Biotechnology, and Systems Biology. He holds additional roles in graduate programs at the Morningside Graduate School of Biomedical Sciences. His research focuses on chromatin regulation in stem cells, cancer biology, and developmental epigenetics. Education and Training: B.S. in Biology, University of Utah (1997) Ph.D. in Molecular & Cellular Biology, University of Washington and Fred Hutchinson Cancer Research Center (2004) Postdoctoral work at University of California, San Francisco (2004–2010) Research Interests: Thomas's lab investigates how chromatin structure influences gene expression and cell fate in embryonic and cancer stem cells. Key projects include studying the Tip60-p400 chromatin remodeling complex, chromatin dynamics during differentiation, and epigenetic mechanisms in cancer stem cells. Techniques used include molecular biology, genomics, and systems-level approaches. Publications: His recent work highlights novel insights into chromatin packaging in sperm (2023), EZH2 inhibition in pancreatic cancer (2023), and EXOC2's role in ALS/FTD (2024). Research trends emphasize multi-omics profiling and epigenetic regulation in disease contexts. Awards: Jane Coffin Childs Memorial Fund Fellowship (Postdoctoral) NIH Pathway to Independence Award Advising & Labs: Offers rotation projects on chromatin regulators, Tip60-p400 mechanisms, and cancer stem cells. Active postdoc positions are available. Collaborations include work with Oliver Rando and Lihua Zhu on chromatin profiling techniques. Labs/Teams: His lab integrates computational and experimental approaches to study dynamic chromatin landscapes, with a focus on translational applications in cancer and regenerative medicine.

Dan Fabrisمشاهده پروفایل

استاد

• Nucleic Acids
• RNA Viruses
• HIV
• +۳ مورد دیگر

Dan Fabris is the Harold S. Schwenk Sr. Distinguished Chair in Chemistry Education at the University of Connecticut's Department of Chemistry. He leads an active research laboratory focused on nucleic acids and their role in infectious diseases. His lab joined UConn in January 2020 and has been steadily growing with multiple new members joining through 2024. Dr. Fabris received his Ph.D. from the University of Padova (Italy) and completed postdoctoral training at the University of Maryland Baltimore County and at the National Research Council in Padova, Italy. His research program investigates structure-function relationships in nucleic acids and protein-nucleic acid complexes that play determinant roles in infectious diseases, with an overarching goal to identify therapeutic targets for HIV, hepatitis C, Zika, and other RNA viruses. His research interests span across nucleic acid biochemistry, virology, and drug discovery. Dr. Fabris employs a cross-disciplinary approach that combines biophysical, biochemical, computational, and omics techniques with novel mass spectrometry technologies developed in his laboratory. His work particularly focuses on regulatory mechanisms of viral processes involving RNA post-transcriptional modifications (PTMs) and their role in mediating the potentiating effects of drugs of abuse on HIV-1 replication. Analysis of Dr. Fabris's recent publications reveals a consistent focus on RNA structure and function, particularly in the context of HIV. His work leverages mass spectrometry techniques to investigate RNA-protein interactions, with special emphasis on TAR RNA and the HIV-1 nucleocapsid protein. His research spans from fundamental structural studies to applied drug discovery, with multiple publications on small molecule inhibitors targeting viral RNA elements. UConn Waring Award (awarded to Daniele Rollo, a student in his lab) UConn Masterton-Hurley Teaching Award (awarded to Sarah Mutchek, a teaching assistant in his lab) Patent awarded to Dan Fabris and lab alumni Rebecca Rose Dr. Fabris actively mentors numerous graduate students and researchers. His lab has welcomed multiple new members in recent years, including Rumbie Chitongo, Joshua Albarracin, Hein Htet, Sienna Brigance, Margrate Anyanwu, Sofia Pezzotti, Alexander Steinberg, Michael Addo, Derek Bobowick, Cole Angell, and Sabrina Daigle. Several of his former students have successfully defended their dissertations (Thomas Kenderdine, Limin Deng) and moved on to positions at Yale School of Medicine (Jyotsna Kumar, Swapna Naik) and Pfizer (Ghazaleh Yassaghi). The lab is equipped with advanced instrumentation including an FT-ICR mass spectrometer delivered in October 2020.

Allen W. Cowley, Jr.مشاهده پروفایل

استاد

• Cardiovascular Physiology
• Genetics and Genomics
• Renal Physiology
• +۴ مورد دیگر

Allen W. Cowley, Jr. is the Harry & Gertrude Hack Term Professor and Chair of the Department of Physiology at the Medical College of Wisconsin since 1980. He holds a PhD in Physiology from Hahnemann Medical University (1968) and a BA in Economics from Trinity College (1961). His research focuses on cardiovascular and renal physiology, hypertension mechanisms, and physiological genomics, with over 325 peer-reviewed publications and continuous NIH funding since 1971. **Research Interests**: Dr. Cowley pioneered studies on baroreceptor reflexes, renin-angiotensin system, renal medullary circulation, and hypertension genetics. His work demonstrated how reduced renal medullary blood flow contributes to chronic hypertension, and he advanced the field of physiological genomics by linking genetic variants to complex diseases. He leads two NIH-funded programs: one on kidney-based blood pressure control and another on salt-sensitive hypertension genetics. **Awards & Leadership**: He served as APS President, IUPS President, and AHA Council Chair. His honors include the Walter Cannon, Ernest Starling, and Carl Wiggers Awards (APS), Novartis Award, and AHA Distinguished Scientist Award. **Advising & Grants**: He has mentored over 50 trainees and directs NIH program projects. His lab explores oxidative stress in hypertension, renal injury mechanisms, and metabolic responses to high salt intake. **Labs/Teams**: His laboratory integrates systems biology, genomics, and experimental physiology to uncover genetic and molecular bases of hypertension and renal dysfunction.

Víctor García Taguaمشاهده پروفایل

استادیار

• Molecular Genetics
• Preventive Medicine
• Public Health
• +۵ مورد دیگر

Víctor García Tagua serves as Assistant Professor at the University of La Laguna within the Department of Obstetrics, Gynecology, Pediatrics, Preventive Medicine, Public Health, Toxicology, Forensic Medicine and Parasitology. He teaches in Pharmacy and Nutrition degree programs while conducting research through the ITB Institute and EpiGeM Epidemiology research group. Education: Bachelor of Biology (2000-2005), University of Seville PhD in Molecular Genetics (2012), University of Seville (Thesis: "Genomic approach to light-regulated transcription in Phycomyces blakesleeanus ") His research spans molecular genetics, microbiology, and clinical epidemiology with current focus on Klotho protein's role in cardiovascular and renal diseases. Early work examined light-regulated transcription in fungi and vesicle trafficking in Aspergillus , followed by bacterial signal transduction in Pseudomonas . Since 2018, he investigates Klotho-FGF23 pathways in vascular calcification, diabetic complications, and renal-cardiovascular axis. His approach integrates molecular biology with clinical epidemiology, recently developing camelid-derived antibodies and repurposing pentoxifylline for kidney disease. Analysis of his 15 most recent publications (2020-2025) reveals a clear trajectory from basic molecular mechanisms to clinical applications. Key themes include Klotho epigenetics in vascular disease (47% of articles), microbial systems biology (20%), and therapeutic repurposing (13%). The work demonstrates strong translational focus with 73% involving human clinical samples or patient data, emphasizing biomarker validation and therapeutic interventions. Research Leadership: Principal Investigator: Agustín de Betancourt technology transfer project (2020-2022) on mini-antibody production in Canarian camels Member: EpiGeM Clinical, Genetic and Molecular Epidemiology research group Member: GEO-GLOBAL Environmental Geochemistry and Global Change group He actively participates in scientific dissemination through Pint of Science, Desgranando Ciencia, MacaroNight, and Science Week events, bridging academic research with public understanding of science.

Xing Fuمشاهده پروفایل

دانشیار

• Stem Cell Biology
• Cardiac Fibrosis
• Adipogenesis
• +۳ مورد دیگر

Xing Fu is the Ralph and Lela Boulware Associate Professor at Louisiana State University's School of Animal Sciences, with a joint appointment in Biological and Agricultural Engineering. His research program investigates stem and progenitor cell biology in adipose, cardiac, and muscle tissues using advanced genomic methodologies. Education: PhD in Animal Science, Washington State University (2011-2015) MS in Biology, Arkansas State University (2008-2010) BS in Biotechnology, Henan Normal University (2003-2007) Postdoctoral Fellowship, Cincinnati Children’s Hospital (2016-2017) Dr. Fu's laboratory employs genomic tools (single-cell RNAseq, ATACseq, Cut&Tag) to examine: Molecular mechanisms of cardiac fibrosis and fibroblast differentiation Depot-specific regulation of adipogenesis in metabolic tissues Progenitor cell dynamics in skeletal muscle development His recent publications demonstrate a consistent focus on tissue remodeling mechanisms, particularly through chromatin accessibility mapping and progenitor cell lineage tracing in metabolic and cardiovascular contexts. Dr. Fu directs an active research laboratory investigating fibrogenic and adipogenic processes ( Lab Website ).

Nancy E. Davidsonمشاهده پروفایل

استاد

• Breast Cancer Research
• Epigenetics
• Oncology
• +۳ مورد دیگر

Nancy E. Davidson, MD, is the Executive Vice President of Clinical Affairs at Fred Hutchinson Cancer Center and holds the Raisbeck Endowed Chair for Collaborative Research. As a Fred Hutch Professor in the Clinical Research Division, she leads translational and clinical research in breast cancer, focusing on epigenetics and hormonal pathways. Her work bridges Fred Hutch’s research programs with clinical care through the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium. Education: MD from Harvard Medical School, BA in Molecular Biology from Wellesley College. Past leadership roles include President of the American Association for Cancer Research (2016-2017) and the American Society of Clinical Oncology (2007-2008). Research interests center on epigenetic mechanisms in hormone-resistant breast cancer, including DNA methylation and histone modifications. Her lab pioneered studies on estrogen receptor regulation and apoptosis induction in breast cancer cells, leading to clinical trials of epigenetic modifiers. She chairs the Breast Committee for the Eastern Cooperative Oncology Group and co-founded the Translational Breast Cancer Research Consortium (TBCRC). Key achievements include establishing new therapeutic regimens for breast cancer through trials on endocrine therapy optimization, taxanes, and trastuzumab. Recognized for advancing evidence-based clinical pathways and oncology cost-effectiveness through ASCO initiatives. Affiliations include membership in the Immunotherapy and Translational Data Science Integrated Research Centers at Fred Hutch. Clinical expertise focuses on breast cancer management and oncology clinical trial design.

• Neurotoxicology
• Neurodegenerative Diseases
• Environmental Health
• +۳ مورد دیگر

Jason Richardson is the Dianne Isakson Distinguished Professor in the Department of Physiology and Pharmacology at the University of Georgia’s College of Veterinary Medicine, where he leads the Isakson Center for Neurological Disease Research. His research focuses on environmental chemical exposures and genetic susceptibility as contributors to neurological diseases such as Alzheimer’s and Parkinson’s. Key areas include neurotoxicology, translational approaches to disease mechanisms, and the impact of pesticide exposure across lifespans. Research Interests: Dr. Richardson investigates how pesticides and heavy metals interact with genetic factors to drive neurodegenerative processes. His work integrates animal models, omics technologies, and epidemiological data to uncover pathways linking environmental toxins to amyloid pathology, neuroinflammation, and neuronal dysfunction. Scientific Contributions: Highlighted the role of DDT and manganese in accelerating Alzheimer’s pathology in mice. Linked prenatal pesticide exposure to midlife cognitive decline and amyloid biomarkers. Explored exercise as a neuroprotective strategy in Parkinson’s models. Awards: Holds the endowed Dianne Isakson Distinguished Professorship. Labs/Teams: His work is conducted through the Isakson Center, focusing on interdisciplinary collaborations in neurotoxicology and translational neuroscience.

Regina Ensenauerمشاهده پروفایل

استاد

• Early origins of childhood obesity
• Fetal programming
• Nutrient-sensing mechanisms
• +۳ مورد دیگر

Regina Ensenauer is a Professor of Experimental Pediatrics and Metabolism at Heinrich Heine University Düsseldorf, affiliated with the University Children’s Hospital. Her research focuses on early-life origins of childhood obesity, fetal programming, and metabolic disease prevention. She leads the PEACHES cohort study investigating maternal obesity’s long-term effects on offspring. As an Anna Boyksen Fellow at the TUM Institute for Advanced Study, her work addresses preventive pediatrics. Her academic journey includes a medical degree from Heidelberg University, residency in Pediatrics at Freiburg, and postdoctoral training at the Mayo Clinic. Awards include the Friedrich-Linneweh Award (2012) and Mayo Alumni Scientific Award (2005). Her research spans metabolite profiling, placental metabolism, and nutritional interventions, with emphasis on translational strategies to combat obesity. Key publications address insulin resistance in maternal obesity, fatty acid metabolism in pregnancy, and neurodevelopmental impacts of dietary PUFAs. Her work integrates clinical, molecular, and epidemiological approaches to understand obesity’s developmental origins, aiming to inform preventive public health policies.

• Pediatric Oncology
• Retinoblastoma
• Langerhans Cell Histiocytosis
• +۳ مورد دیگر

Rima Jubran, MD, MPH, is a Clinical Professor of Pediatrics at the Keck School of Medicine of the University of Southern California and a pediatric oncologist at Children’s Hospital Los Angeles (CHLA). She serves as the Designated Institutional Official and Director of Graduate Medical Education at CHLA, overseeing all physician training programs. Her clinical focus includes retinoblastoma, histiocytic disorders, and pediatric solid tumors. Dr. Jubran earned her MD from Case Western Reserve University and an MPH from George Washington University, followed by residency and fellowship training in pediatric hematology/oncology. Her research emphasizes retinoblastoma and Langerhans cell histiocytosis, with contributions to treatment protocols, liquid biopsy applications, and genomic analysis. She actively collaborates with international groups like the Children’s Oncology Group and North American Consortium for Histiocytic Disorders. Dr. Jubran has been recognized with prestigious awards, including the USC Academic Senate Faculty Service Award (2023) and leadership fellowships in academic medicine. Her work bridges clinical care, education, and research, with notable publications on therapeutic response biomarkers, genomic instability in tumors, and multimodal treatment strategies. She also advocates for medical educator development and serves on nonprofit boards addressing histiocytosis and pediatric oncology care.

• Beta Cell Biology
• Stem Cell Research
• Regenerative Medicine
• +۴ مورد دیگر

Senta K. Georgia is an Associate Professor of Pediatrics and Stem Cell Biology & Regenerative Medicine at the Keck School of Medicine of the University of Southern California , where she is also a Principal Investigator at the Center for Endocrinology, Diabetes, and Metabolism at Children’s Hospital Los Angeles (CHLA) . She was promoted to associate professor in 2023 and became the first Black PhD scientist to earn tenure at the Keck School since its founding in 1885. Education: BS in Biological Sciences from Stanford University (with dual departmental honors), PhD in Molecular Biology from UCLA Postdoctoral training: Hillblom Islet Research Center, UCLA Georgia’s research focuses on pancreatic beta cell differentiation during organogenesis , beta cell proliferation in metabolic stress , and beta cell regeneration for diabetes therapy . Her work emphasizes DNA methylation mechanisms in defining beta cell identity and exploring CRISPR-Cas9 technology for genetic diabetes. Recent studies include investigating how pregnancy hormones boost beta cells via serotonin and the role of cell cycle molecules in beta cell mass regulation. Her publications span diabetes pathophysiology , ß-cell biology , and regenerative medicine , with key contributions to understanding DNMT1-p53 interactions in pancreatic organogenesis and Skp2-p27 pathways in beta cell adaptive expansion. Current projects include CRISPR-based cures for rare diabetes and stem cell therapy development. Georgia leads the USC COMPASS program ($2.9M CIRM grant) to diversify stem cell science and chairs admissions for the PhD Programs in Biomedical & Biological Sciences (PIBBS) at Keck. She co-led the DEI committee for her department and advocates for underrepresented students in STEM. Labs/Teams: Georgia Lab at USC Stem Cell, collaborations with female faculty in USC Biomedical Engineering and Chemistry departments, partnerships with JEDI-WeST for institutional climate interventions.

• Head and Neck Cancer
• Signal Transduction
• Precision Medicine
• +۳ مورد دیگر

Jennifer Grandis, MD, is the American Cancer Society Professor of Otolaryngology at the University of California, San Francisco (UCSF) School of Medicine. Her research focuses on head and neck squamous cell carcinoma (HNSCC), with an emphasis on signal transduction pathways, precision medicine, and translational therapies. Dr. Grandis leads initiatives to identify predictive biomarkers and develop targeted treatments, leveraging patient-derived xenograft models and genomic data. Education: MD from the University of Pittsburgh School of Medicine (1987), followed by residency and fellowship in Otolaryngology and Infectious Disease at the same institution. Previously held leadership roles at the University of Pittsburgh, including Vice Chair for Research in Otolaryngology. Research Interests: Genetic and epigenetic alterations in HNSCC, EGFR/STAT3 signaling, PI3K pathway mutations, and HPV-associated cancers. Her work bridges clinical observations with preclinical models to advance therapies like EGFR antisense gene therapy and STAT3 inhibition. Grants & Awards: NIH R01DE028289 (2019–2024): Targeting STAT3 in HNSCC NIH R35CA231998 (2018–2025): PI3K pathway mutations in HPV+ HNSCC Chancellor’s Distinguished Research Award (2009) Institute of Medicine (IOM) Member (2012) Labs & Teams: Leads translational research programs integrating genomics, proteomics, and clinical trials. Collaborates with institutions like MD Anderson and Carnegie Mellon on molecular oncology and drug development.

Lisa Christianمشاهده پروفایل

استاد

• Psychoneuroimmunology
• Maternal and Child Health
• Health Disparities
• +۳ مورد دیگر

Dr. Lisa Christian is a Professor of Psychiatry & Behavioral Health at The Ohio State University (OSU), holding a joint appointment in Psychology and serving as Director of the Stress, Behavioral Immunology, and Health Disparities Lab within the Institute for Behavioral Medicine Research. She is also the Medical Student Advocate in the College of Medicine, advocating for a positive learning environment. Her research integrates psychoneuroimmunology to study how chronic stress, mood disorders, sleep disturbances, and social determinants (e.g., race, socioeconomic status) interact with immune and neuroendocrine systems to impact health outcomes, particularly in pregnant women, caregivers of dementia patients, and cancer patients. Over 800 women have participated in her studies, emphasizing health disparities. Dr. Christian’s work has been funded by NIH institutes (NIA, NIMHD, NICHD, NINR) and private foundations. She has authored over 70 peer-reviewed articles and chapters. Key honors include the Robert Ader New Investigator Award (2016) and Neal Miller Young Investigator Award (2016). Her clinical practice focuses on cognitive behavioral therapy for anxiety, depression, and sleep disorders in women. Current projects include the CHAMP study (multiple myeloma caregiving), the CARE study (dementia caregiving), and the NCHAT-BIO study (family stress and health). Education: PhD in Clinical Health Psychology from OSU (post-internship at University of Florida). Outside academia, she enjoys vegetarian cooking, travel, and family time with her two children and Bernedoodles.

Alexandra Lusserمشاهده پروفایل

استاد

• Chromatin remodeling
• Chromatin assembly
• Epigenetics
• +۵ مورد دیگر

Professor Alexandra Lusser serves as Professor and Deputy Head in the Department of Molecular Biology at Innsbruck Medical University, where she leads the Chromatin and Epigenetics Laboratory. Her research focuses on understanding the molecular mechanisms of chromatin assembly, remodeling, and epigenetic regulation at both DNA and RNA levels. Professor Lusser completed her PhD at the University of Innsbruck in 1998, followed by postdoctoral training at the University of California, San Diego (2001-2004) in the laboratory of Professor JT Kadonaga. She joined Innsbruck Medical University as Assistant Professor in 2004, achieved her Habilitation for Molecular Biology in 2008, was promoted to Associate Professor, and became a full Professor in 2019. Her research program investigates how eukaryotic DNA is organized in chromatin and how this organization affects DNA metabolism processes including transcription, replication, repair, and recombination. A significant portion of her work examines ATP-dependent chromatin assembly and remodeling mechanisms, variant histone assembly, and epigenetic mechanisms at the mRNA level, particularly mRNA base modifications such as 5-methylcytosine and their roles in mRNA metabolism and translation. Her publications reveal a strong focus on developing and applying innovative biochemical and genomic techniques to study RNA modifications and chromatin dynamics. Professor Lusser's extensive publication record spanning from 1996 to the present demonstrates consistent contributions to the fields of chromatin biology and RNA epigenetics. Her recent work shows particular emphasis on developing novel sequencing methods for RNA modification analysis, exploring the functional consequences of RNA modifications, and investigating the relationship between chromatin remodeling factors and neurological functions. HOECHST Award (1998) APART 3-year postdoctoral fellowship from the Austrian Academy of Sciences (2001) START Prize from the Ministry of Science and Research (2005) Member of the Young Curia of the Austrian Academy of Sciences (2008-2016) Research Award from the State Capital Innsbruck (2009) As Deputy Head of the Department of Molecular Biology, Professor Lusser contributes to departmental leadership while maintaining an active research program. Her laboratory has developed several important methodologies including TUC-Seq for measuring mRNA transcription and degradation rates, bisulfite sequencing for detecting 5-methylcytosine in RNA, and other innovative approaches for studying RNA modifications. Her work bridges molecular biology, biochemistry, and genomics, with implications for understanding fundamental biological processes and potential applications in disease research.

• Hematology
• Oncology
• Clinical Trials
• +۳ مورد دیگر

Dr. Iris Isufi is an Associate Professor of Medicine (Hematology) at Yale School of Medicine and Co-Director of the Adult CAR T-Cell Therapy Program. She serves as Co-Leader of the Cellular Therapy Clinical Research Team at Yale Cancer Center and co-chairs the Cellular Therapy (CT)-SAFE Committee. MD from State University of New York at Stony Brook (2004) Residency at Albert Einstein College of Medicine/Montefiore Medical Center (2007) Fellowship at Yale University School of Medicine (2011) Her research focuses on hematologic malignancies , particularly aggressive lymphomas and stem cell transplantation . She leads phase I-III clinical trials in lymphoma treatment and cellular therapies , with recent work examining CAR T-cell monitoring, vaccine responses in transplant patients, and novel chemotherapy combinations. 2024-2025 publications highlight expertise in transformed lymphomas , T-cell malignancies , multiple myeloma , and post-transplant care . Key methodologies include CAR T-cell therapy optimization , epigenetic drug combinations , and real-world effectiveness studies . Scientific Awards ASCO/AACR Methods in Clinical Cancer Research Workshop Fellow (2008) Outstanding House Officer in Internal Medicine (2007) Kijeon Yoo Award for Medical Education Determination (2004) Medical School Merit Scholarship (2004) As a principal investigator in multiple clinical trials, Dr. Isufi bridges early drug development and transplantation medicine to improve outcomes for lymphoma patients. Her collaborations with Yale's Hematology team reflect deep institutional integration.